Xbrane Sets Date For Latest Run At Ranibizumab In US

Awaits Manufacturing Sites Inspection Ahead Of October BsUFA Date

 
• By Dave Wallace
  
Xbrane is eyeing FDA approval in October (Shutterstock)

More from Biosimilars

More from Manufacturing